ARWR
Price
$67.74
Change
+$1.95 (+2.96%)
Updated
Sep 17 closing price
Capitalization
9.29B
73 days until earnings call
Intraday BUY SELL Signals
AXON
Price
$453.50
Change
-$14.92 (-3.19%)
Updated
Sep 17 closing price
Capitalization
38.05B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARWR vs AXON

ARWR vs AXON Comparison Chart in %
View a ticker or compare two or three
VS
ARWR vs. AXON commentary
Sep 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and AXON is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($38.1B) has a higher market cap than ARWR($9.29B). AXON has higher P/E ratio than ARWR: AXON (195.18) vs ARWR (48.72). ARWR YTD gains are higher at: 2.033 vs. AXON (-20.149). AXON has higher annual earnings (EBITDA): 406M vs. ARWR (-133.67M). ARWR has more cash in the bank: 1.6B vs. AXON (693M). ARWR has less debt than AXON: ARWR (984M) vs AXON (1.83B). AXON has higher revenues than ARWR: AXON (3.22B) vs ARWR (669M).
ARWRAXONARWR / AXON
Capitalization9.29B38.1B24%
EBITDA-133.67M406M-33%
Gain YTD2.033-20.149-10%
P/E Ratio48.72195.1825%
Revenue669M3.22B21%
Total Cash1.6B693M231%
Total Debt984M1.83B54%
FUNDAMENTALS RATINGS
ARWR vs AXON: Fundamental Ratings
ARWR
AXON
OUTLOOK RATING
1..100
5759
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
9067
SMR RATING
1..100
9881
PRICE GROWTH RATING
1..100
4963
P/E GROWTH RATING
1..100
2333
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXON's Valuation (88) in the Biotechnology industry is in the same range as ARWR (91). This means that AXON’s stock grew similarly to ARWR’s over the last 12 months.

AXON's Profit vs Risk Rating (67) in the Biotechnology industry is in the same range as ARWR (90). This means that AXON’s stock grew similarly to ARWR’s over the last 12 months.

AXON's SMR Rating (81) in the Biotechnology industry is in the same range as ARWR (98). This means that AXON’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's Price Growth Rating (49) in the Biotechnology industry is in the same range as AXON (63). This means that ARWR’s stock grew similarly to AXON’s over the last 12 months.

ARWR's P/E Growth Rating (23) in the Biotechnology industry is in the same range as AXON (33). This means that ARWR’s stock grew similarly to AXON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARWRAXON
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 5 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 9 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
58%
COMPARISON
Comparison
Sep 18, 2026
Stock price -- (ARWR: $67.74 vs. AXON: $453.50)
Brand notoriety: ARWR: Notable vs. AXON: Not notable
ARWR represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ARWR: 193% vs. AXON: 116%
Market capitalization -- ARWR: $9.29B vs. AXON: $38.05B
ARWR [@Biotechnology] is valued at $9.29B. AXON’s [@Aerospace & Defense] market capitalization is $38.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.09B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $4.49 to $1.99T. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Aerospace & Defense] industry is $40.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green while AXON’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than AXON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 6 bearish.
  • AXON’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ARWR and AXON are a bad buy in the short-term.

Price Growth

ARWR (@Biotechnology) experienced а -18.15% price change this week, while AXON (@Aerospace & Defense) price change was -5.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +17.12%. For the same industry, the average monthly price growth was -4.65%, and the average quarterly price growth was +7.71%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +0.69%. For the same industry, the average monthly price growth was -14.48%, and the average quarterly price growth was -5.50%.

Reported Earning Dates

ARWR is expected to report earnings on Nov 30, 2026.

AXON is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+17.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+0.69% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

View a ticker or compare two or three
ARWR
Daily Signal:
Gain/Loss:
AXON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICHR52.961.54
+2.99%
Ichor Holdings
CYTK69.920.53
+0.76%
Cytokinetics
IBAC10.940.01
+0.09%
IB Acquisition Corp.
SPEGU10.53N/A
N/A
Silver Pegasus Acquisition Corp
RZLT3.95-0.03
-0.75%
Rezolute

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
-3.19%
TECH - AXON
61%
Loosely correlated
+0.11%
VCYT - AXON
58%
Loosely correlated
+5.38%
BEAM - AXON
57%
Loosely correlated
+6.80%
SEER - AXON
56%
Loosely correlated
+1.05%
ADPT - AXON
56%
Loosely correlated
+3.18%
More